1. Ultra-fast detection of pathogens and protein biomarkers using a low-cost silicon plasmonic biosensing platform
- Author
-
Athanasios Manolis, Christia Eleftheriou, Mahmoud A. Elrabiaey, George Tsekenis, Sabato D'Auria, Antonio Varriale, Alessandro Capo, Maria Staiano, Bartos Chmielak, Anna Lena Schall-Giesecke, Stephan Suckow, and Dimitris Tsiokos
- Subjects
Bacteria detection ,Protein detection ,Silicon photonics ,Plasmonic transducer ,Lab on chip ,Biosensor ,Instruments and machines ,QA71-90 - Abstract
In this paper, we report, for the first time to our knowledge, a new versatile and future proof diagnostic platform for diverse applications and heterogeneous biological targets. This platform relies on a plasmonic-augmented silicon photonic biochip to detect bacteria and protein biomarkers within minutes. To demonstrate the potential of this platform in diverse applications, we demonstrate the detection of two heterogeneous targets, the bacterium Escherichia coli (E. coli) and the molecule C-reactive protein (CRP) using a universal detection method. E. coli is one of the most commonly encountered bacterial pathogens involved in food monitoring, food born infections and water contamination applications, while CRP is a well-established disease severity indicator frequently used in common clinical practice. The biochip used is fully compatible with CMOS semiconductor manufacturing, while it hosts biosensors arrays for any combination of detection assays. Each biosensor exploits a 70 μm long aluminum plasmonic transducer within a silicon nitride waveguide-based Mach–Zehnder Interferometer. Each aluminum surface was silanized and biomodified with specific antibodies. Biosensing experiments revealed that CRP can be detected in diverse sample mediums, and E. coli detection was achieved in buffer at concentrations as low as 10 cells/ml within 13–25 min. The results are in good agreement with preceding numerical simulations. The modular nature of the reported biosensing platform makes it scalable and customizable, allowing nearly any combination of diagnostic tests targeting pathogens and proteins to be integrated on the same biochip for food quality monitoring, environmental monitoring, drug discovery and modern cell therapy manufacturing, or biomedical applications.
- Published
- 2024
- Full Text
- View/download PDF